AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Oncology Institute Inc. (TOI)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

0.89

-0.07 (-7.29%)

At close: Feb 20, 2025, 3:59 PM

0.89

0.65%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	0.85
Market Cap	67.10M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.77
PE Ratio (ttm)	-1.15
Forward PE	n/a
Analyst	Buy

Ask	0.95
Volume	251,986
Avg. Volume (20D)	1,836,618
Open	0.95
Previous Close	0.96
Day's Range	0.88 - 0.95
52-Week Range	0.13 - 2.10
Beta	undefined

About TOI

The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants ser...

[Show more]

Industry Medical - Care Facilities

Sector Healthcare

IPO Date Jun 4, 2020

Employees 800

Stock Exchange NASDAQ

Ticker Symbol TOI

Website https://theoncologyinstitute.com

Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for TOI stock is "Buy." The 12-month stock price forecast is $2.5, which is an increase of 181.50% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Oncology Institute Inc. is scheduled to release its earnings on Mar 26, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

3 months ago

-23.47%

The Oncology Institute shares are trading lower. T... Unlock content with Pro Subscription

6 months ago

-18.18%

The Oncology Institute shares are trading lower after the company reported worse-than-expected Q2 financial results. Also the reiterated issued FY24 revenue guidance with its midpoint below estimates and cut its gross profit and adjusted EBITDA guidance.

News

3 months ago · seekingalpha.com

The Oncology Institute, Inc. (TOI) Q3 2024 Earnings Call Transcript

The Oncology Institute, Inc. (NASDAQ:TOI ) Q3 2024 Earnings Conference Call November 13, 2024 5:00 PM ET Company Participants Mark Hueppelsheuser - General Counsel Daniel Virnich - CEO Rob Carter - CF...